Key facts
- It has raised $13.8M.
- Notable investors include Parkwalk Advisors, Ada Ventures, University of Bristol, Change Makers, Medtronic MiniMed — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Carbometrics
- ·The full record, as it builds
Funding rounds
No funding rounds for Carbometrics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Carbometrics
Developer of a synthetic glucose-binding molecule designed for glucose sensing applications. The company's technology is a selective synthetic receptor for glucose that is produced through a streamlined and scalable synthesis, exhibiting robustness against high temperatures, prolonged solution exposure, extreme pH levels, and steam sterilization, enabling healthcare professionals to develop advanced glucose detection methods for various uses.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2018
- Employees
- 16
- Website
- carbometrics.com/
- Ownership
- Privately Held (backing)
Carbometrics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Carbometrics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Carbometrics in its N-PORT filings yet. We sweep new filings monthly.